본문 바로가기

카테고리 없음

Global ANTIBODY THERAPEUTICS AND BLOOD ANTIBODY THERAPEUTICS Market Report 2023-2029

Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.

 

Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.

 

 

 

According to the new market research report “Global ANTIBODY THERAPEUTICS AND BLOOD ANTIBODY THERAPEUTICS Market Report 2023-2029”, published by QYResearch, the global ANTIBODY THERAPEUTICS AND BLOOD ANTIBODY THERAPEUTICS market size is projected to reach USD 406.24 billion by 2029, at a CAGR of 10.0% during the forecast period.

 

Figure.   Global ANTIBODY THERAPEUTICS AND BLOOD ANTIBODY THERAPEUTICS Market Size (US$ Million), 2018-2029

Based on or includes research from QYResearch: Global ANTIBODY THERAPEUTICS AND BLOOD ANTIBODY THERAPEUTICS Market Report 2023-2029.

 

Figure.   Global ANTIBODY THERAPEUTICS AND BLOOD ANTIBODY THERAPEUTICS Top 13 Players Ranking and Market ShareBased on data of 2021, Continually updated

Based on or includes research from QYResearch: 2021 data information of Global ANTIBODY THERAPEUTICS AND BLOOD ANTIBODY THERAPEUTICS Market Report 2023-2029.

 

The global key manufacturers of ANTIBODY THERAPEUTICS AND BLOOD ANTIBODY THERAPEUTICS include Roche, Abbvie, J & J, Amgen, Merck, Novartis, Bristol-Myers Squibb, Alexion Pharmaceuticals, Takeda, Biogen, etc. In 2020, the global top five players had a share approximately 56.0% in terms of revenue.

 

 

 

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.